Suppr超能文献

使用骨形态发生蛋白进行直接外侧腰椎椎间融合后的早期融合率

Early Fusion Rates After Direct Lateral Lumbar Interbody Fusion With Bone-Morphogenetic Protein.

作者信息

Zhang Hanci, Dial Brian, Brown Christopher

机构信息

Department of Orthopaedic Surgery, Duke University Medical Center; Durham, North Carolina.

出版信息

Int J Spine Surg. 2021 Jun;15(3):423-428. doi: 10.14444/8063. Epub 2021 May 7.

Abstract

BACKGROUND

Direct lateral (transpsoas) lumbar interbody fusion (LLIF) reportedly achieves union by 1 year postoperatively, but how soon fusion occurs after these minimally invasive procedures is unclear. This study investigated LLIF fusion progression at 6 months and 1 year in a large-scale cohort using bone morphogenetic protein (BMP) graft and examined risk factors associated with failed fusion.

METHODS

Patients undergoing primary LLIF with a single surgical team from 2015 through 2016 with polyetheretherketone (PEEK) iimplants and BMP graft were identified. Retrospective chart review included demographics and medical history, construct length and location, and concurrent L5-S1 fusion. Inclusion criteria included minimum 1-year follow-up and postoperative lumbar computed tomography at 6 months and 1 year, which was independently assessed for bony union at each level.

RESULTS

166 patients underwent LLIF at a total of 312 levels. Seventy-nine patients (48%) underwent 1-level fusion; 45 (27%), 2 levels; and 42 (25%), 3 or more levels. At 6 months, 160 (51%) levels showed fusion. At 1 year, 70% of the remainder were fused, and total fusion rate was 85%. Fusion rates from L1 through L4 were similar (84%-87%). Nonunion was not significantly associated with construct length ( .19), concurrent anterior L5-S1 interbody fusion ( .50), age ( .70), BMI ( .15), or comorbidities such as diabetes ( .86) or thyroid disease ( .46).

CONCLUSIONS

This large retrospective cohort study corroborates prior 1-year LLIF fusion rate reports (85%) independent of construct length or location or medical comorbidities. Significantly, half showed fusion by 6 months, earlier than previously described and validating the efficacy of LLIF.

LEVEL OF EVIDENCE

CLINICAL RELEVANCE

This study presents a large cohort of patients to support effective lumbar fusion after LLIF with BMP-2.

摘要

背景

据报道,直接外侧(经腰大肌)腰椎椎间融合术(LLIF)在术后1年实现融合,但在这些微创手术后融合多快发生尚不清楚。本研究在一个使用骨形态发生蛋白(BMP)移植物的大规模队列中调查了6个月和1年时的LLIF融合进展情况,并检查了与融合失败相关的危险因素。

方法

确定2015年至2016年由单一手术团队进行初次LLIF且使用聚醚醚酮(PEEK)植入物和BMP移植物的患者。回顾性病历审查包括人口统计学和病史、植入物长度和位置以及同期L5 - S1融合情况。纳入标准包括至少1年的随访以及6个月和1年时的术后腰椎计算机断层扫描,对每个节段的骨融合情况进行独立评估。

结果

166例患者共进行了312个节段的LLIF。79例患者(48%)进行了1节段融合;45例(27%)进行了2节段融合;42例(25%)进行了3个或更多节段融合。在6个月时,160个(51%)节段显示融合。在1年时,其余节段中有70%实现融合,总融合率为85%。L1至L4节段的融合率相似(84% - 87%)。不融合与植入物长度(P = 0.19)、同期L5 - S1前路椎间融合(P = 0.50)、年龄(P = 0.70)、体重指数(P = 0.15)或合并症如糖尿病(P = 0.86)或甲状腺疾病(P = 0.46)均无显著相关性。

结论

这项大型回顾性队列研究证实了先前的1年LLIF融合率报告(85%),且与植入物长度、位置或内科合并症无关。重要的是,半数患者在6个月时显示融合,比先前描述的时间更早,验证了LLIF的疗效。

证据级别

5级。

临床相关性

本研究展示了一大队列患者,以支持使用BMP - 2的LLIF术后有效的腰椎融合。

相似文献

1
Early Fusion Rates After Direct Lateral Lumbar Interbody Fusion With Bone-Morphogenetic Protein.
Int J Spine Surg. 2021 Jun;15(3):423-428. doi: 10.14444/8063. Epub 2021 May 7.
5
Nerve injury after lateral lumbar interbody fusion: a review of 919 treated levels with identification of risk factors.
Spine J. 2014 May 1;14(5):749-58. doi: 10.1016/j.spinee.2013.06.066. Epub 2013 Sep 5.
7
Contralateral psoas seroma after transpsoas lumbar interbody fusion with bone morphogenetic protein-2 implantation.
Spine J. 2013 Feb;13(2):e1-5. doi: 10.1016/j.spinee.2012.11.052. Epub 2013 Jan 12.
8
Graft subsidence as a predictor of revision surgery following stand-alone lateral lumbar interbody fusion.
J Neurosurg Spine. 2018 Jan;28(1):50-56. doi: 10.3171/2017.5.SPINE16427. Epub 2017 Nov 10.

本文引用的文献

1
Cost-Utility Analysis of rhBMP-2 Use in Adult Spinal Deformity Surgery.
Spine (Phila Pa 1976). 2020 Jul 15;45(14):1009-1015. doi: 10.1097/BRS.0000000000003442.
2
Lateral and Oblique Lumbar Interbody Fusion-Current Concepts and a Review of Recent Literature.
Curr Rev Musculoskelet Med. 2019 Jun 22;12(3):305-310. doi: 10.1007/s12178-019-09562-6.
3
Fusion Rates of Lateral Lumbar Interbody Fusion Using Recombinant Human Bone Morphogenetic Protein-2.
Global Spine J. 2019 Jun;9(4):398-402. doi: 10.1177/2192568218797097. Epub 2018 Sep 25.
4
Comparison of transforaminal lumbar interbody fusion outcomes in patients receiving rhBMP-2 versus autograft.
Spine J. 2018 Mar;18(3):439-446. doi: 10.1016/j.spinee.2017.08.230. Epub 2017 Aug 18.
5
A radiographic analysis of cage positioning in lateral transpsoas lumbar interbody fusion.
J Orthop. 2016 Nov 22;14(1):142-146. doi: 10.1016/j.jor.2016.10.028. eCollection 2017 Mar.
6
Lateral interbody fusion combined with open posterior surgery for adult spinal deformity.
J Neurosurg Spine. 2016 Dec;25(6):697-705. doi: 10.3171/2016.4.SPINE16157. Epub 2016 Jun 24.
8
Exploratory meta-analysis on dose-related efficacy and morbidity of bone morphogenetic protein in spinal arthrodesis surgery.
J Neurosurg Spine. 2016 Mar;24(3):457-75. doi: 10.3171/2015.4.SPINE141086. Epub 2015 Nov 27.
9
Lateral lumbar interbody fusion for sagittal balance correction and spinal deformity.
J Clin Neurosci. 2015 Nov;22(11):1714-21. doi: 10.1016/j.jocn.2015.03.050. Epub 2015 Jul 17.
10
Fusion rate following extreme lateral lumbar interbody fusion.
Eur Spine J. 2015 Apr;24 Suppl 3:369-71. doi: 10.1007/s00586-015-3929-7. Epub 2015 Apr 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验